These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19426202)

  • 41. An introduction to chemokines and their roles in transfusion medicine.
    Davenport RD
    Vox Sang; 2009 Apr; 96(3):183-98. PubMed ID: 19076338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sirolimus-containing graft-versus-host disease prophylaxis in patients with lymphoma.
    Mehta J
    J Clin Oncol; 2009 Oct; 27(28):e138; author reply e139-40. PubMed ID: 19720890
    [No Abstract]   [Full Text] [Related]  

  • 43. A syndrome resembling homologous disease after short-term cross-circulation in rabbits.
    Teramatsu T; Yazaki J; Kinoshita S; Kato Y; Funazu T
    Acta Tuberc Jpn; 1966 Dec; 16(2):39-47. PubMed ID: 5984177
    [No Abstract]   [Full Text] [Related]  

  • 44. Total lymphoid irradiation for graft-versus-host disease protection.
    Kohrt H; Lowsky R
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S23-6. PubMed ID: 19561409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: impact of chronic graft-versus-host disease.
    Valcárcel D; Martino R; Piñana JL; Sierra J
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S35-7. PubMed ID: 19561412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Post-transfusional graft versus host disease. Apropos of 3 cases].
    Moncharmont P; Souillet G; Rigal D; Paris A; Philippe N; David M; Jouvenceaux A
    Ann Pediatr (Paris); 1988 Apr; 35(4):247-51. PubMed ID: 3389699
    [No Abstract]   [Full Text] [Related]  

  • 47. Graft-versus-host disease.
    Petz LD
    N Engl J Med; 1993 Aug; 329(9):664-5. PubMed ID: 8341353
    [No Abstract]   [Full Text] [Related]  

  • 48. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
    Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
    J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
    Mahindra A; Bolwell B; Sobecks R; Rybicki L; Pohlman B; Dean R; Andresen S; Sweetenham J; Kalaycio M; Copelan E
    Br J Haematol; 2009 Aug; 146(3):310-6. PubMed ID: 19508292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Graft versus host reaction after blood transfusion].
    Lahtinen R; Lahti J; Koskimies S; Hänninen A; Collan Y
    Duodecim; 1981; 97(4):199-203. PubMed ID: 7238376
    [No Abstract]   [Full Text] [Related]  

  • 51. [Consideration of blood transfusion in cardiac surgery].
    Ninomiya K
    Rinsho Kyobu Geka; 1988 Feb; 8(1):7-11. PubMed ID: 9301808
    [No Abstract]   [Full Text] [Related]  

  • 52. Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation.
    Saad AG; Alyea EP; Wen PY; Degirolami U; Kesari S
    J Clin Oncol; 2009 Oct; 27(30):e147-9. PubMed ID: 19667266
    [No Abstract]   [Full Text] [Related]  

  • 53. Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report.
    Piton G; Larosa F; Minello A; Becker MC; Mantion G; Aubin F; Deconinck E; Hillon P; Di Martino V
    Liver Transpl; 2009 Jul; 15(7):682-5. PubMed ID: 19562700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients.
    Ludajic K; Balavarca Y; Bickeböller H; Rosenmayr A; Fischer GF; Faé I; Kalhs P; Pohlreich D; Kouba M; Dobrovolna M; Greinix HT
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1400-6. PubMed ID: 19822299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emerging drugs for acute graft-versus-host disease.
    Khaled Y; Reddy P; Krijanovski O
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):219-32. PubMed ID: 19519285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Irradiation eradication and pathogen reduction. Ceasing cesium irradiation of blood products.
    Mintz PD; Wehrli G
    Bone Marrow Transplant; 2009 Aug; 44(4):205-11. PubMed ID: 19617907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Haematopoietic stem cell transplantation and oral complications].
    Raber-Durlacher JE; von dem Borne PA; Stokman MA; Gortzak RA
    Ned Tijdschr Tandheelkd; 2009 Jun; 116(6):330-5. PubMed ID: 19585886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
    Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
    Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.